Immunome - IMNM Net Assets per Single Share

Graphic logo of Immunome, Inc. (IMNM)

Immunome, Inc. (IMNM) leads the search for tumor-fighting antibodies using AI-driven B-cell analysis, confirming a market trend on GURU.Markets where the indicator stands at 4.62. The company minimizes risks through a pool of independent oncology projects. To ensure the stability of biomaterial supplies, Immunome, Inc. (IMNM) is expanding its laboratory network, optimizing transport chains and eliminating potential delivery disruptions.

Immunome Inc (IMNM): Share Book Value from 07/04/2022 to 10/27/2026

immunome.com - analytical breakdowns and key metrics (IMNM)

- price and consensus price forecast:
Price Chart Immunome Corp|IMNM - Broker Consensus Forecast
- market capitalization data:
Market Value Immunome, Inc.|IMNM - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Immunome|IMNM - Net Asset Value|Market Capitalization to Book Value Ratio immunome.com|IMNM - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Immunome, Inc.|IMNM - Long-Term Debt to Capital|Short-Term Debt to Equity Immunome|IMNM - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Immunome, Inc.
Fundamental company valuation:Immunome Corp - IMNM
Manufactured products of Immunome

This metric reflects the portion of equity attributable to a single share after deducting all liabilities. Growth in this metric indicates a strengthening financial foundation and enhanced investment security. By analyzing the book value per share, an investor determines the intrinsic value of the business relative to its market price. For Immunome, Inc. (IMNM), such asset stability supports the aggressive development of its R&D center. High capitalization allows the company to effectively retain leading biochemists through a system of stock options.

Competitors of Immunome, Inc. (IMNM)

Argenx (ARGX) - Net Assets per Single Share|BNTX: Equity per Share|ABVX (Abivax Corp) - Net Assets per Single Share|ADMA (admabiologics.com) - Accounting Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|Book Value per Share ENGN (enGene Bio)|RAPT: Net Assets per Share|JBIO (aerovatetx.com) - Net Assets per Single Share|ACRS (aclaristx.com) - Accounting Value per Share|Net Assets per Single Share KYTX|Accounting Value per Share Tiziana Life Sciences Ltd. (TLSA)|Accounting Value per Share CABA|Book Value per Share VTYX (Ventyx Biosciences, Inc)|THTX - Net Assets per Single Share|avalotx.com - Equity per Share|ELDN (Eledon Pharmaceuticals, Inc.) - Net Assets per Single Share|AGEN: Net Asset Value per Share|CLYM (Climb Bio, Inc.) - Net Assets per Single Share|Zura Bio Ltd (ZURA) - Accounting Value per Share|Book Value per Share ATYR (aTyr Pharma, Inc.)|Net Asset Value per Share Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Accounting Value per Share|Accounting Value of a Share shattucklabs.com (STTK)|Book Value per Share EQ|Connect Biopharma Holdings - Net Assets per Share|Immunic Inc (IMUX) - Net Assets per Single Share|ATRA - Equity per Share|IFRX (inflarx.de) - Book Value per Share|Accounting Value per Share X4 Pharmaceuticals Inc.|ACET: Accounting Value per Share|Net Assets per Share Celularity Corp|INMB (INmune Bio, Inc.) - Book Value per Share|Net Assets per Share BRNS (barinthusbio.com)|Kezar Life Sciences, Inc. - Net Assets per Single Share|SAB Biotherapeutics Inc. - Accounting Value per Share|Akari Therapeutics plc (AKTX) - Net Assets per Single Share|ENLV: Equity per Share|QTTB (q32bio.com) - Net Assets per Single Share|GOVX (geovax.com) - Accounting Value per Share|Net Assets per Single Share Edesa Biotech EDSA|Share Book Value iBio Inc|Carisma Therapeutics (CARM) - Book Value per Share|Accounting Value of a Share XTL Bio (XTLB)|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. - Book Value per Share|Net Assets per Single Share Aptevo (APVO)|AIM: Accounting Value of a Share|ADTX (aditxt.com) - Net Assets per Single Share|GRI Bio Corporation (GRI) - Accounting Value per Share|XRTX (XORTX Therapeutics Inc.) - Book Value per Share|Book Value per Share reshapelifesciences.com (HIND)|Revelation Biosciences, Inc. (REVB) - Accounting Value per Share|Accounting Value of a Share Indaptus Therapeutics Inc (INDP)|Book Value per Share SCNI|CalciMedica Inc - Net Assets per Share|AFMD: Net Assets per Single Share|ALLK: Accounting Value per Share|HOOK (hookipapharma.com) - Net Assets per Single Share|Accounting Value per Share IGM Biosciences|ITOS (iTeos) - Accounting Value per Share|Book Value per Share OCEA|Net Assets per Single Share TC Biopharm TCBP|Equity per Share thirdharmonicbio.com (THRD)